MAPT and Alzheimer disease: Already over 40 years ago, electron microscopy and PET imaging revealed altered mitochondrial morphology and decreased glucose metabolism in AD brains [27], a parameter that appears superior to tau or Aβ pathology in predicting AD progression [28].